Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Study Purpose
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Recruitment Criteria
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
Eligible Ages | 12 Years and Over |
Gender | All |
Key
Inclusion Criteria:
1. Subjects who may benefit from study participation in the opinion of the investigator and had participated in a prior nemolizumab study for AD. 2. Female subjects of childbearing potential (ie, fertile, following menarche and until becoming post-menopausal unless permanently sterile) must agree either to be strictly abstinent throughout the study and for 12 weeks after the last study drug injection, or to use an effective and approved method of contraception throughout the study and for 12 weeks after the last study drug injection. KeyExclusion Criteria:
1. Subjects who, during their participation in a prior nemolizumab study, experienced an AE which in the opinion of the investigator could indicate that continued treatment with nemolizumab may present an unreasonable risk for the subject. 2. Pregnant women, breastfeeding women, or women planning a pregnancy during the clinical study. 3. Body weight < 30 kg. 4. Cutaneous infection within 1 week before the baseline visit, any infection requiring treatment with oral or parenteral antibiotics, antivirals, antiparasitics or antifungals within 2 weeks before the baseline visit, or any confirmed or suspected coronavirus disease (COVID)-19 infection within 2 weeks before the screening or baseline visit. Subjects may be rescreened once the infection has resolved. Resolution of COVID-19 infection can be confirmed by recovery assessment methods. 5. History of hypersensitivity (including anaphylaxis) to an immunoglobulin product (plasma-derived or recombinant, eg, monoclonal antibody) 6. Any clinically significant issue, based investigator judgementTrial Details
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT03989206 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 3 |
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
Galderma R&D |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
N/A |
Principal Investigator Affiliation | N/A |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Industry |
Overall Status | Active, not recruiting |
Countries | Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom, United States |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Moderate-to-Severe Atopic Dermatitis |
Long-term study to assess the safety and efficacy of nemolizumab in subjects with moderate-to-severe AD
Arms
Experimental: Nemolizumab
Nemolizumab administered via subcutaneous injection
Interventions
Drug: - Nemolizumab
Nemolizumab
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
Galderma Investigational Site 8749
Birmingham, Alabama, 35244
Status
Address
Galderma Investigational Site 8893
Birmingham, Alabama, 35244
Status
Address
Galderma Investigational Site 8866
Guntersville, Alabama, 35976
Status
Address
Galderma Investigational Site 8808
Scottsdale, Arizona, 85255
Status
Address
Galderma Investigational Site 8873
Scottsdale, Arizona, 85260
Status
Address
Galderma Investigational Site 8447
Fort Smith, Arkansas, 72916
Status
Address
Galderma Investigational Site 8880
North Little Rock, Arkansas, 72117
Status
Address
Galderma Investigational Site 8831
Anaheim, California, 92801
Status
Address
Galderma Investigational Site 8906
Bell Gardens, California, 90201
Status
Address
Galderma Investigational Site 8456
Beverly Hills, California, 90212
Status
Address
Galderma Investigational Site 8578
Cerritos, California, 90703
Status
Address
Galderma Investigational Site 8577
Encinitas, California, 92024
Status
Address
Galderma Investigational Site 8636
Fountain Valley, California, 92708
Status
Address
Galderma Investigational Site 8224
Fremont, California, 94538
Status
Address
Galderma Investigational Site 8791
Fresno, California, 93720
Status
Address
Galderma Investigational Site 8888
Fullerton, California, 92835
Status
Address
Galderma Investigational Site 8845
Huntington Beach, California, 92647
Status
Address
Galderma Investigational Site 8833
Inglewood, California, 90301
Status
Address
Galderma Investigational Site 8686
Lomita, California, 90717
Status
Address
Galderma Investigational Site 8674
Los Angeles, California, 90025
Status
Address
Galderma Investigational Site 8683
Los Angeles, California, 90033
Status
Address
Galderma Investigational Site 8813
Los Angeles, California, 90057
Status
Address
Galderma Investigational Site 8907
Newport Beach, California, 92660
Status
Address
Galderma Investigational Site 8799
Ontario, California, 91762
Status
Address
Galderma Investigational Site 8745
Pasadena, California, 91105
Status
Address
Galderma Investigational Site 8671
San Diego, California, 92108
Status
Address
Galderma Investigational Site 8692
San Diego, California, 92121
Status
Address
Galderma Investigational Site 8658
San Diego, California, 92123
Status
Address
Galderma Investigational Site 8125
San Francisco, California, 94115
Status
Address
Galderma Investigational Site 8536
Santa Ana, California, 92705
Status
Address
Galderma Investigational Site 8608
Santa Monica, California, 90404
Status
Address
Galderma Investigational Site 8820
Westminster, California, 92683
Status
Address
Galderma Investigational Site 8637
Farmington, Connecticut, 06606
Status
Address
Galderma Investigational Site 8870
Boca Raton, Florida, 33433
Status
Address
Galderma Investigational Site 8805
Cape Coral, Florida, 33991
Status
Address
Galderma Investigational Site 8786
Clearwater, Florida, 33765
Status
Address
Galderma Investigational Site 8902
Doral, Florida, 33122
Status
Address
Galderma Investigational Site 8391
Hialeah, Florida, 33016
Status
Address
Galderma Investigational Site 8804
Hialeah, Florida, 33016
Status
Address
Galderma Investigational Site 8711
Jacksonville, Florida, 32256
Status
Address
Galderma Investigational Site 8836
Jacksonville, Florida, 32256
Status
Address
Galderma Investigational Site 8523
Largo, Florida, 33770
Status
Address
Galderma Investigational Site 8850
Margate, Florida, 33063
Status
Address
Galderma Investigational Site 8806
Miami Lakes, Florida, 33014
Status
Address
Galderma Investigational Site 8800
Miami Lakes, Florida, 33016
Status
Address
Galderma Investigational Site 8719
Miami, Florida, 33125
Status
Address
Galderma Investigational Site 8851
Miami, Florida, 33135
Status
Address
Galderma Investigational Site 8656
Miami, Florida, 33137
Status
Address
Galderma Investigational Site 8801
Miami, Florida, 33145
Status
Address
Galderma Investigational Site 8704
Miami, Florida, 33155
Status
Address
Galderma Investigational Site 8737
Miami, Florida, 33174
Status
Address
Galderma Investigational Site 8706
Miami, Florida, 33175
Status
Address
Galderma Investigational Site 8708
Miami, Florida, 33176
Status
Address
Galderma Investigational Site 8856
Ormond Beach, Florida, 33174
Status
Address
Galderma Investigational Site 8734
Pembroke Pines, Florida, 33028
Status
Address
Galderma Investigational Site 8203
Tampa, Florida, 33607
Status
Address
Galderma Investigational Site 8816
Tampa, Florida, 33613
Status
Address
Galderma Investigational Site 8889
Tampa, Florida, 33613
Status
Address
Galderma Investigational Site 8839
Tampa, Florida, 33615
Status
Address
Galderma Investigational Site 8126
West Palm Beach, Florida, 33401
Status
Address
Galderma Investigational Site 8667
Columbus, Georgia, 31904
Status
Address
Galderma Investigational Site 8744
Macon, Georgia, 31217
Status
Address
Galderma Investigational Site 8728
Newnan, Georgia, 30263
Status
Address
Galderma Investigational Site 8707
Stockbridge, Georgia, 30281
Status
Address
Galderma Investigational Site 8819
Nampa, Idaho, 83687
Status
Address
Galderma Investigational Site 9916
Chicago, Illinois, 60611
Status
Address
Galderma Investigational Site 8739
Normal, Illinois, 61761
Status
Address
Galderma Investigational Site 8729
Rolling Meadows, Illinois, 60008
Status
Address
Galderma Investigational Sites 8571
Skokie, Illinois, 60076
Status
Address
Galderma Investigational Site 8712
Skokie, Illinois, 60077
Status
Address
Galderma Investigational Site 8142
Indianapolis, Indiana, 46250
Status
Address
Galderma Investigational Site 8724
New Albany, Indiana, 47150
Status
Address
Galderma Investigational Site 9934
Shawnee Mission, Kansas, 66216
Status
Address
Galderma Investigational Site 8771
Louisville, Kentucky, 40241-6162
Status
Address
Galderma Investigational Site 8882
Bangor, Maine, 04401
Status
Address
Galderma Investigational Site 8743
Ann Arbor, Michigan, 48109
Status
Address
Galderma Investigational Site 8512
Bay City, Michigan, 48706
Status
Address
Galderma Investigational Site 8554
Detroit, Michigan, 48202
Status
Address
Galderma Investigational Site 8617
Farmington Hills, Michigan, 48334
Status
Address
Galderma Investigational Site 8155
Troy, Michigan, 48084
Status
Address
Galderma Investigational Site 8849
Troy, Michigan, 48084
Status
Address
Galderma Investigational Site 8226
Warren, Michigan, 48088
Status
Address
Galderma Investigational Site 8748
Ypsilanti, Michigan, 48197
Status
Address
Galderma Investigational Site 8521
Saint Joseph, Missouri, 64506
Status
Address
Galderma Investigational Site 8718
Missoula, Montana, 59808
Status
Address
Galderma Investigational Site 8810
Omaha, Nebraska, 68144
Status
Address
Galderma Investigational Site 8740
Henderson, Nevada, 89002
Status
Address
Galderma Investigational Site 8825
Las Vegas, Nevada, 89106
Status
Address
Galderma Investigational Site 8675
Las Vegas, Nevada, 89119
Status
Address
Galderma Investigational Site 8109
Lebanon, New Hampshire, 03766
Status
Address
Galderma Investigational Site 8506
Hackensack, New Jersey, 07601
Status
Address
Galderma Investigational Site 8826
Albuquerque, New Mexico, 87106
Status
Address
Galderma Investigational Site 8242
Brooklyn, New York, 11203
Status
Address
Galderma Investigational Site 8741
Buffalo, New York, 14221
Status
Address
Galderma Investigational Site 8723
Cortland, New York, 13045
Status
Address
Galderma Investigational Site 8828
Forest Hills, New York, 11375
Status
Address
Galderma Investigational Site 9925
Glendale, New York, 11385
Status
Address
Galderma Investigational Site 8733
New York, New York, 10022
Status
Address
Galderma Investigational Site 8620
New York, New York, 10023
Status
Address
Galderma Investigational Site 8279
New York, New York, 10075
Status
Address
Galderma Investigational Site 8772
Durham, North Carolina, 27710
Status
Address
Galderma Investigational Site 8795
Shelby, North Carolina, 28150
Status
Address
Galderma Investigational Site 8726
Wilmington, North Carolina, 28405-3176
Status
Address
Galderma Investigational Site 8648
Wilmington, North Carolina, 28405
Status
Address
Galderma Investigational Site 8702
Bexley, Ohio, 43209
Status
Address
Galderma Investigational Site 8747
Cincinnati, Ohio, 45219
Status
Address
Galderma Investigational Site 8595
Dublin, Ohio, 43016
Status
Address
Galderma Investigational Site 8206
Norman, Oklahoma, 73071
Status
Address
Galderma Investigational Site 8857
Oklahoma City, Oklahoma, 73118
Status
Address
Galderma Investigational Site 8212
Portland, Oregon, 97210
Status
Address
Galderma Investigational Site 8255
Philadelphia, Pennsylvania, 19103
Status
Address
Galderma Investigational Site 8721
Pittsburgh, Pennsylvania, 15213
Status
Address
Galderma Investigational Site 8802
Plymouth Meeting, Pennsylvania, 19462
Status
Address
Galderma Investigational Site 8777
Charleston, South Carolina, 29407
Status
Address
Galderma Investigational Site 8736
Charleston, South Carolina, 29425
Status
Address
Galderma Investigational Site 8713
North Charleston, South Carolina, 29420
Status
Address
Galderma Investigational Site 8818
Rapid City, South Dakota, 57702
Status
Address
Galderma Investigational Site 8133
Arlington, Texas, 76011
Status
Address
Galderma Investigational Site 8298
Austin, Texas, 78723
Status
Address
Galderma Investigational Site 8238
Dallas, Texas, 75230
Status
Address
Galderma Investigational Site 8245
Dallas, Texas, 75231
Status
Address
Galderma Investigational Site 8827
Dripping Springs, Texas, 78620
Status
Address
Galderma Investigational Site 8664
Frisco, Texas, 75034
Status
Address
Galderma Investigational Site 8807
Houston, Texas, 77029
Status
Address
Galderma Investigational Site 8042
Houston, Texas, 77056
Status
Address
Galderma Investigational Site 8670
Houston, Texas, 77401
Status
Address
Galderma Investigational Site 8817
Katy, Texas, 77494
Status
Address
Galderma Investigational Site 8787
Plano, Texas, 75093
Status
Address
Galderma Investigational Site 8329
San Antonio, Texas, 78229
Status
Address
Galderma Investigational Site 8618
Waco, Texas, 76710
Status
Address
Galderma Investigational Site 8003
Webster, Texas, 77598
Status
Address
Galderma Investigational Site 8672
Salt Lake City, Utah, 84117
Status
Address
Galderma Investigational Site 8738
Burke, Virginia, 22015
Status
Address
Galderma Investigational Site 8862
Fairfax, Virginia, 22031
Status
Address
Galderma Investigational Site 8896
Richmond, Virginia, 23219
Status
Address
Galderma Investigational Site 8434
Seattle, Washington, 98105
International Sites
Status
Address
Galderma Investigational Site 5441
Darlinghurst, New South Wales, 2010
Status
Address
Galderma Investigational Site 5759
Kogarah, New South Wales, 2217
Status
Address
Galderma Investigational Site 6152
Westmead, New South Wales, 2145
Status
Address
Galderma Investigational Site 5638
Benowa, Queensland, 4217
Status
Address
Galderma Investigational Site 6161
Brisbane, Queensland, 4102
Status
Address
Galderma Investigational Site 6159
Woodville, South Australia, 5011
Status
Address
Galderma Investigational Site 6131
Carlton, Victoria, 3053
Status
Address
Galderma Investigational Site 5366
East Melbourne, Victoria, 3002
Status
Address
Galderma Investigational Site 5458
Parkville, Victoria, 3050
Status
Address
Galderma Investigational Site 6160
Parkville, Victoria, 3052
Status
Address
Galderma Investigational Site 6153
Victoria Park, Western Australia, 6100
Status
Address
Galderma Investigational Site 6156
Linz, Oberoesterreich, 4020
Status
Address
Galderma Investigational Site 6157
Graz, Styria, 8036
Status
Address
Galderma Investigational Site 6194
Vienna, , 1090
Status
Address
Galderma Investigational Site 6158
Vienna, , 1220
Status
Address
Galderma Investigational Site 6038
Leuven, Vlaams-Brabant, 3000
Status
Address
Galderma Investigational Site 5448
Brussels, , 1200
Status
Address
Galderma Investigational Site 6163
Edegem, , 2650
Status
Address
Galderma Investigational Site 6164
Gent, , 9000
Status
Address
Galderma Investigational Site 6162
Liège, , 4000
Status
Address
Galderma Investigational Site 6029
Pleven, , 5800
Status
Address
Galderma Investigational Site 6051
Sofia, , 1407
Status
Address
Galderma Investigational Site 6078
Sofia, , 1408
Status
Address
Galderma Investigational Site 6102
Sofia, , 1431
Status
Address
Galderma Investigational Site 6165
Sofia, , 1431
Status
Address
Galderma Investigational Site 6216
Sofia, , 1528
Status
Address
Galderma Investigational Site 6046
Sofia, , 1606
Status
Address
Galderma Investigational Site 6080
Sofia, , 1606
Status
Address
Galderma Investigational Site 6101
Sofia, , 1612
Status
Address
Galderma Investigational Site 6079
Sofia, , 1618
Status
Address
Galderma Investigational Site 6250
Sofia, , 1784
Status
Address
Galderma Investigational Site 6136
Stara Zagora, , 6000
Status
Address
Galderma Investigational Site 6251
Stara Zagora, , 6000
Status
Address
Galderma Investigational Site 8085
Calgary, Alberta, T2G 1B1
Status
Address
Galderma Investigational Site 8903
Calgary, Alberta, T2J 7E1
Status
Address
Galderma Investigational Site 8215
Calgary, Alberta, T3E 0B2
Status
Address
Galderma Investigational Site 8824
Edmonton, Alberta, T6G 1C3
Status
Address
Galderma Investigational Site 8722
Edmonton, Alberta, T6G 1C9
Status
Address
Galderma Investigational Site 8161
Surrey, British Columbia, V3V 0C6
Status
Address
Galderma Investigational Site 8586
Barrie, Ontario, L4M 7G1
Status
Address
Galderma Investigational Site 8904
Guelph, Ontario, N1L 0B7
Status
Address
Galderma Investigational Site 8780
Niagara Falls, Ontario, L2H 1H5
Status
Address
Galderma Investigational Site 8610
Ottawa, Ontario, K1G 6C6
Status
Address
Galderma Investigational Site 8901
Ottawa, Ontario, K1H 7X3
Status
Address
Galderma Investigational Site 8336
Toronto, Ontario, M3H 5Y8
Status
Address
Galderma Investigational Site 8899
Toronto, Ontario, M4W 2N4
Status
Address
Galderma Investigational Site 8731
Waterloo, Ontario, N2J 1C4
Status
Address
Galderma Investigational Site 8000
Saint John, , A1C 2H5
Status
Address
Galderma Investigational Site 6055
Brno, , 656 91
Status
Address
Galderma Investigational Site 5225
Náchod, , 547 01
Status
Address
Galderma Investigational Site 6030
Olomouc, , 779 00
Status
Address
Galderma Investigational Site 6024
Prague, , 100 00
Status
Address
Galderma Investigational Site 6240
Prague, , 120 00
Status
Address
Galderma Investigational Site 6021
Praha, , 110 00
Status
Address
Galderma Investigational Site 6054
Praha, , 110 00
Status
Address
Galderma Investigational Site 6025
Praha, , 150 06
Status
Address
Galderma Investigational Site 6068
Tallinn, , 10134
Status
Address
Galderma Investigational Site 6069
Tallinn, , 10138
Status
Address
Galderma Investigational Site 6067
Tartu, , 50417
Status
Address
Galderma Investigational Site 6198
Le Mans, , 72037
Status
Address
Galderma Investigational Site 5031
Lille, , 59037
Status
Address
Galderma Investigational Site 6170
Martigues, , 13500
Status
Address
Galderma Investigational Site 6167
Nantes, , 44093
Status
Address
Galderma Investigational Site 5140
Nice, , 06200
Status
Address
Galderma Investigational Site 6133
Paris, , 75015
Status
Address
Galderma Investigational Site 6166
Paris, , 75475
Status
Address
Galderma Investigational Site 5407
Pierre-Bénite, , 69495
Status
Address
Galderma Investigational Site 6135
Quimper, , 29107
Status
Address
Galderma Investigational Site 6197
Toulon, , 83800
Status
Address
Galderma Investigational Site 6169
Toulouse, , 31000
Status
Address
Galderma Investigational Site 6168
Valence, , 26000
Status
Address
Galderma Investigational Site 6224
Tbilisi, , 0159
Status
Address
Galderma Investigational Site 6228
Tbilisi, , 0159
Status
Address
Galderma Investigational Site 6235
Tbilisi, , 0159
Status
Address
Galderma Investigational Site 6238
Tbilisi, , 0159
Status
Address
Galderma Investigational Site 6227
Tbilisi, , 0186
Status
Address
Galderma Investigational Site 6230
Tbilisi, , 0186
Status
Address
Galderma Investigational Site 6234
Tbilisi, , 0186
Status
Address
Galderma Investigational Site 6236
Zugdidi, , 2100
Status
Address
Galderma Investigational Site 5482
Aachen, , 52074
Status
Address
Galderma Investigational Site 5566
Augsburg, , 86179
Status
Address
Galderma Investigational Site 6022
Bad Bentheim, , 48455
Status
Address
Galderma Investigational Site 6110
Berlin, , 13055
Status
Address
Galderma Investigational Site 6061
Bielefeld, , 33647
Status
Address
Galderma Investigational Site 6082
Bonn, , 53127
Status
Address
Galderma Investigational Site 6062
Buxtehude, , 21614
Status
Address
Galderma Investigational Site 5368
Darmstadt, , 64283
Status
Address
Galderma Investigational Site 6132
Dresden, , 01097
Status
Address
Galderma Investigational Site 6028
Dülmen, , 48249
Status
Address
Galderma Investigational Site 6031
Düsseldorf, , 40225
Status
Address
Galderma Investigational Site 5442
Gera, , 07548
Status
Address
Galderma Investigational Site 6081
Goettigen, , 37075
Status
Address
Galderma Investigational Site 6062
Halle, , 06120
Status
Address
Galderma Investigational Site 6041
Hamburg, , 20251
Status
Address
Galderma Investigational Site 6150
Hamburg, , 20537
Status
Address
Galderma Investigational Site 6040
Hamburg, , 22391
Status
Address
Galderma Investigational Site 5469
Heidelberg, , 69120
Status
Address
Galderma Investigational Site 6086
Kiel, , 24148
Status
Address
Galderma Investigational Site 6146
Langenau, , 89129
Status
Address
Galderma Investigational Site 6084
Mainz, , 55131
Status
Address
Galderma Investigational Site 5382
Munich, , 80337
Status
Address
Galderma Investigational Site 6039
Münster, , 48149
Status
Address
Galderma Investigational Site 5918
Osnabrück, , 49074
Status
Address
Galderma Investigational Site 6109
Stuttgart, , 70499
Status
Address
Galderma Investigational Site 6214
Tuebingen, , 72076
Status
Address
Galderma Investigational Site 6147
Budapest, , 1036
Status
Address
Galderma Investigational Site 5513
Budapest, , 1085
Status
Address
Galderma Investigational Site 5567
Debrecen, , 4025
Status
Address
Galderma Investigational Site 6026
Debrecen, , 4032
Status
Address
Galderma Investigational Site 6254
Gyula, , 5700
Status
Address
Galderma Investigational Site 6053
Veszprem, , 8200
Status
Address
Galderma Investigational Site 6145
Bologna, , 40138
Status
Address
Galderma Investigational Site 6045
L'Aquila, , 67100
Status
Address
Galderma Investigational Site 6049
Roma, , 00168
Status
Address
Galderma Investigational Site 6177
Rome, , 00144
Status
Address
Galderma Investigational Site 6155
Rozzano, , 20089
Status
Address
Galderma Investigational Site 6175
Vicenza, , 36100
Status
Address
Galderma Investigational Site 6095
Bucheon-Si, , 14584
Status
Address
Galderma Investigational Site 6100
Busan, , 49241
Status
Address
Galderma Investigational Site 6098
Gyeonggi-do, , 15355
Status
Address
Galderma Investigational Site 6154
Gyeonggi-Do, , 18450
Status
Address
Galderma Investigational Site 6138
Incheon, , 21431
Status
Address
Galderma Investigational Site 6120
Incheon, , 21565
Status
Address
Galderma Investigational Site 6093
Incheon, , 22332
Status
Address
Galderma Investigational Site 6105
Seoul, , 02841
Status
Address
Galderma Investigational Site 5659
Seoul, , 03080
Status
Address
Galderma Investigational Site 6116
Seoul, , 03722
Status
Address
Galderma Investigational Site 6129
Seoul, , 04763
Status
Address
Galderma Investigational Site 6103
Seoul, , 05030
Status
Address
Galderma Investigational Site 6056
Seoul, , 06591
Status
Address
Galderma Investigational Site 6094
Seoul, , 06973
Status
Address
Galderma Investigational Site 6099
Seoul, , 07441
Status
Address
Galderma Investigational Site 6113
Liepaja, , LV-3401
Status
Address
Galderma Investigational Site 6134
Riga, , LV-1006
Status
Address
Galderma Investigational Site 6059
Riga, , LV-1009
Status
Address
Galderma Investigational Site 6060
Talsi, , LV-3201
Status
Address
Galderma Investigational Site 6111
Kaunas, , LT-50161
Status
Address
Galderma Investigational Site 6073
Vilnius, , LT-07195
Status
Address
Galderma Investigational Site 6112
Vilnius, , LT-08411
Status
Address
Galderma Investigational Site 6212
Groningen, , 9713
Status
Address
Galderma Investigational Site 6108
Rotterdam, , 3015 GD
Status
Address
Galderma Investigational Site 6027
Utrecht, , 3584 CX
Status
Address
Galderma Investigational Site 6119
Hamilton, , 3204
Status
Address
Galderma Investigational Site 6118
Wellington, , 6021
Status
Address
Galderma Investigational Site 5773
Białystok, , 15-453
Status
Address
Galderma Investigational Site 6097
Chorzów, , 41-500
Status
Address
Galderma Investigational Site 6255
Czestochowa, , 42-202
Status
Address
Galderma Investigational Site 6075
Gdańsk, , 80-214
Status
Address
Galderma Investigational Site 6243
Gdańsk, , 80-382
Status
Address
Galderma Investigational Site 5138
Gdańsk, , 80-803
Status
Address
Galderma Investigational Site 6244
Gdynia, , 81-537
Status
Address
Galderma Investigational Site 6087
Katowice, , 40-040
Status
Address
Galderma Investigational Site 5021
Katowice, , 40-611
Status
Address
Galderma Investigational Site 5362
Kraków, , 30-033
Status
Address
Galderma Investigational Site 6052
Kraków, , 31-559
Status
Address
Galderma Investigational Site 5367
Lublin, , 20-080
Status
Address
Galderma Investigational Site 6071
Lublin, , 20-081
Status
Address
Galderma Investigational Site 5377
Nowa Sól, , 67-100
Status
Address
Galderma Investigational Site 6063
Olsztyn, , 10-229
Status
Address
Galderma Investigational Site 6237
Ostrowiec Świętokrzyski, , 27-400
Status
Address
Galderma Investigational Site 6085
Poznań, , 60-529
Status
Address
Galderma Investigational Site 6127
Poznań, , 60-702
Status
Address
Galderma Investigational Site 5495
Rzeszów, , 35-055
Status
Address
Galderma Investigational Site 6088
Rzeszów, , 35-055
Status
Address
Galderma Investigational Site 6223
Szczecin, , 70-332
Status
Address
Galderma Investigational Site 6130
Szczecin, , 71-434
Status
Address
Galderma Investigational Site 6048
Tarnow, , 33-100
Status
Address
Galderma Investigational Site 6126
Warsaw, , 01-142
Status
Address
Galderma Investigational Site 5707
Warsaw, , 01-817
Status
Address
Galderma Investigational Site 6065
Warszawa, , 01-192
Status
Address
Galderma Investigational Site 6122
Warszawa, , 02-507
Status
Address
Galderma Investigational Site 6242
Warszawa, , 02-793
Status
Address
Galderma Investigational Site 6064
Warszawa, , 02-953
Status
Address
Galderma Investigational Site 6222
Warszawa, , 02-962
Status
Address
Galderma Investigational Site 6047
Wrocław, , 50-381
Status
Address
Galderma Investigational Site 6185
Wrocław, , 50-566
Status
Address
Galderma Investigational Site 6096
Wrocław, , 51-318
Status
Address
Galderma Investigational Site 5005
Wrocław, , 53-658
Status
Address
Galderma Investigational Site 6245
Łódź, , 90-127
Status
Address
Galderma Investigational Site 5570
Łódź, , 90-265
Status
Address
Galderma Investigational Site 5363
Łódź, , 90-436
Status
Address
Galderma Investigational Site 6231
Łódź, , 94-050
Status
Address
Galderma Investigational Site 6124
Singapore, , 119228
Status
Address
Galderma Investigational Site 6077
Singapore, , 169608
Status
Address
Galderma Investigational Site 5499
Singapore, , 308205
Status
Address
Galderma Investigational Site 6057
Alicante, , 03010
Status
Address
Galderma Investigational Site 6037
Barcelona, , 08036
Status
Address
Galderma Investigational Site 6035
Barcelona, , 08916
Status
Address
Galderma Investigational Site 5580
L'Hospitalet De Llobregat, , 08907
Status
Address
Galderma Investigational Site 6106
Las Palmas De Gran Canaria, , 35010
Status
Address
Galderma Investigational Site 6058
Madrid, , 28006
Status
Address
Galderma Investigational Site 5842
Madrid, , 28034
Status
Address
Galderma Investigational Site 6190
Madrid, , 28046
Status
Address
Galderma Investigational Site 6186
Madrid, , 28222
Status
Address
Galderma Investigational Site 6036
Madrid, , 28223
Status
Address
Galderma Investigational Site 5551
Madrid, , 28922
Status
Address
Galderma Investigational Site 6191
Pamplona, , 31008
Status
Address
Galderma Investigational Site 6202
Barnsley, , S75 3DL
Status
Address
Galderma Investigational Site 6207
Blackpool, , FY2 0JH
Status
Address
Galderma Investigational Site 6203
Cannock, , WS11 0BN
Status
Address
Galderma Investigational Site 6090
Dudley, , DY1 2HQ
Status
Address
Galderma Investigational Site 6104
Glasgow, , G3 8SJ
Status
Address
Galderma Investigational Site 6204
Liverpool, , L34 1BH
Status
Address
Galderma Investigational Site 6121
London, , SE1 9RT
Status
Address
Galderma Investigational Site 6205
Manchester, , M13 9NQ
Status
Address
Galderma Investigational Site 6208
Newcastle, , NE1 4LP
Status
Address
Galderma Investigational Site 6206
Stockton-on-Tees, , TS17 6EW